According to health officials, the United States is acquiring another vaccine to treat the fatal disease caused by Coronavirus as the U.S. FDA on July 13 said OK to Novavax doses for adults. The COVID-19 jab manufactured by Novavax,...
On Thursday, the U.S. federal health regulator authorized the use of COVID-19 booster dose jointly developed by Pfizer and its German Partner BioNTech SE for kids of ages 5-11-years after a panel of advisers to the CDC recommended them....
As the White House struggles to secure extra funding for American efforts at home and abroad, on Thursday, Joe Biden, the President of America, urged the world leaders to accelerate financial and policy vows to get Coronavirus vaccine doses...
The President Biden administration is warning that America could possibly see 100M COVID-19 cases coming Fall and cold weather, as US officials widely stress the need for additional funding package from the U.S. Congress to prepare Americans.
The White House...
On Friday, the United Nations health agency said it strongly recommends Paxlovid – Pfizer’s COVID-19 antiviral pill – after studies found that the treatment cut the risk of patients at increased risk of being hospitalized by eighty-five percent. However,...
Coronavirus infections are again trending up in the United States, and about all of them are amid more contagious BA.2 subvariant. BA.2 is also now the dominant virus strain worldwide. According to the latest data from the U.S. CDC,...
American President Joe Biden administration’s mandate that all United States federal workers be inoculated against the fatal Coronavirus disease was maintained on April 7 by a U.S. Court of Appeals. However, in a 2/1 vote, a panel of the...
On Wednesday, the President of America urged the U.S. Congress to pass additional 22B dollars in emergency funding to help continue the battle against the deadly coronavirus pandemic, as he got a 2nd booster shot of the m-RNA jab...
On Wednesday, Moderna Inc, Cambridge, Massachusetts-based pharmaceutical and biotechnology company, said it would request European and U.S. health regulators to approve two lowered-dose shots of its coronavirus jab for kids below six-years of age. The Drug Company said its...
On Monday, the White House said that keeping away from new funding approval from the United States Congress, the US administration is just out of money for coronavirus testing, jabs, and treatment. The US governing body has been involved...
